172 related articles for article (PubMed ID: 34996459)
1. Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis.
Xu P; Hu K; Zhang P; Sun ZG; Zhang N
Cancer Cell Int; 2022 Jan; 22(1):13. PubMed ID: 34996459
[TBL] [Abstract][Full Text] [Related]
2. METTL14-mediated N
Liu Z; Sun T; Piao C; Zhang Z; Kong C
Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
[TBL] [Abstract][Full Text] [Related]
3. Gephyrin suppresses lung squamous cell carcinoma development by reducing mTOR pathway activation.
Zhang X; Cheng D; Liu Y; Wu Y; He Z
Cancer Manag Res; 2019; 11():5333-5341. PubMed ID: 31239782
[No Abstract] [Full Text] [Related]
4. The NRF2 antagonist ML385 inhibits PI3K-mTOR signaling and growth of lung squamous cell carcinoma cells.
Ji L; Moghal N; Zou X; Fang Y; Hu S; Wang Y; Tsao MS
Cancer Med; 2023 Mar; 12(5):5688-5702. PubMed ID: 36305267
[TBL] [Abstract][Full Text] [Related]
5. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
6. PA2G4 promotes the metastasis of hepatocellular carcinoma by stabilizing FYN mRNA in a YTHDF2-dependent manner.
Sun S; Liu Y; Zhou M; Wen J; Xue L; Han S; Liang J; Wang Y; Wei Y; Yu J; Long X; Chen X; Liang H; Huang Z; Zhang B
Cell Biosci; 2022 May; 12(1):55. PubMed ID: 35526051
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-145 Modulates
Yang Z; Li J; Feng G; Gao S; Wang Y; Zhang S; Liu Y; Ye L; Li Y; Zhang X
J Biol Chem; 2017 Mar; 292(9):3614-3623. PubMed ID: 28104805
[No Abstract] [Full Text] [Related]
8. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
9. GNA13 promotes the proliferation and migration of lung squamous cell carcinoma cells through regulating the PI3K/AKT signaling pathway.
Na J; Zhou W; Yin M; Hu Y; Ma X
Tissue Cell; 2022 Jun; 76():101795. PubMed ID: 35413491
[TBL] [Abstract][Full Text] [Related]
10. TSTA3 overexpression promotes malignant characteristics in LUSC by regulating LAMP2-mediated autophagy and tumor microenvironment.
Guo Y; Hao Y; Shen L; Du Y; Wang X; Gao L; Feng X; Zhai Y; Liu Z; Xu E; Yang Y; Xi Y; Yang B; Zhang L
Cancer Cell Int; 2023 Nov; 23(1):285. PubMed ID: 37986192
[TBL] [Abstract][Full Text] [Related]
11. METTL3 Promotes OSCC Progression by Down-Regulating WEE1 in a m6A-YTHDF2-Dependent Manner.
Su Y; Hu Y; Qu B; Lei R; Guo G
Mol Biotechnol; 2024 May; ():. PubMed ID: 38744787
[TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine reader YTHDF2 promotes multiple myeloma cell proliferation through EGR1/p21
Liu R; Miao J; Jia Y; Kong G; Hong F; Li F; Zhai M; Zhang R; Liu J; Xu X; Wang T; Liu H; Hu J; Yang Y; He A
Oncogene; 2023 May; 42(20):1607-1619. PubMed ID: 37012388
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m
Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C
Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274
[TBL] [Abstract][Full Text] [Related]
14. Methyltransferase-like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1.
Liu T; Wang H; Fu Z; Wang Z; Wang J; Gan X; Wang A; Wang L
Cancer Sci; 2022 Feb; 113(2):446-458. PubMed ID: 34813676
[TBL] [Abstract][Full Text] [Related]
15. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
[TBL] [Abstract][Full Text] [Related]
16. N6-Methyladenosine Reader YTHDF2 Enhances Non-Small-Cell Lung Cancer Cell Proliferation and Metastasis through Mediating circ_SFMBT2 Degradation.
Xu J; Shang Y; Qin X; Gai Y; Cai F; Xiao H; Zhou C; Fu Y; Ge X
Contrast Media Mol Imaging; 2022; 2022():1087622. PubMed ID: 35924072
[TBL] [Abstract][Full Text] [Related]
17. The m6A reader YTHDF2 alleviates the inflammatory response by inhibiting IL-6R/JAK2/STAT1 pathway-mediated high-mobility group box-1 release.
Zeng Z; Lan Y; Zhang L; Chen Y; Gong Y; Zuo F; Li J; Luo G; Peng Y; Yuan Z
Burns Trauma; 2023; 11():tkad023. PubMed ID: 38026444
[TBL] [Abstract][Full Text] [Related]
18. YTHDF2 interference suppresses the EMT of cervical cancer cells and enhances cisplatin chemosensitivity by regulating AXIN1.
Wu M; Chen G; Liao X; Xiao L; Zheng J
Drug Dev Res; 2022 Aug; 83(5):1190-1200. PubMed ID: 35489084
[TBL] [Abstract][Full Text] [Related]
19. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis.
Zhao Z; Cai Q; Zhang P; He B; Peng X; Tu G; Peng W; Wang L; Yu F; Wang X
Front Mol Biosci; 2021; 8():657087. PubMed ID: 34179079
[TBL] [Abstract][Full Text] [Related]
20. HIF1A-dependent overexpression of MTFP1 promotes lung squamous cell carcinoma development by activating the glycolysis pathway.
Ji J; Wang Y; Jing A; Ma L; Yang J; Ren D; Lv J; Lv M; Xu M; Yuan Q; Ma X; Qian Q; Wang W; Geng T; Ding Y; Qin J; Liu Y; Zhou J; Zuo L; Ma S; Wang X; Liu B
Heliyon; 2024 Apr; 10(7):e28440. PubMed ID: 38689964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
